Charles River Laboratories (CRL) Key Ratios
$291.76
As on 02-Sep-2026 16:00EDT
Market cap
$14,038 Mln
Revenue (TTM)
$3,999 Mln
P/E Ratio
--
P/B Ratio
4.9
Div. Yield
0 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | 0.83 | -2.72 | -0.74 | -1.45 | 4.09 |
| EBIT | 2,709.69 | -17.63 | -178.82 | -147.05 | -166.41 |
| Net Profit | 85.19 | -104.24 | -237.55 | -179.15 | -188.84 |
| EPS | 89.92 | -102.88 | -266.27 | -180.16 | -191.03 |
| Book Value | -- | -- | -5.01 | 3.54 | 9.18 |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | TTM | Dec-25 | Dec-24 |
| EBIT-Margin
| 7.66 | 11.16 | -1.94 | 0.19 | 5.42 |
| Net Margin
| -- | 11.64 | -5.96 | -- | -- |
| Return on equity
| 3.46 | 8.97 | -8.01 | -4.36 | 0.29 |
| Return on Capital
| 1.76 | 4.27 | -- | -2.33 | 0.16 |
| Return on Assets
| 1.39 | 3.41 | -2.76 | -1.97 | 0.13 |
| Debt to Equity (x)
| -- | -- | 0.92 | 0.97 | 0.79 |
Profitability
ROCE
--
--
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Charles River Laboratories (CRL)
|
--
|
-2.33
|
0.16
|
7.45
|
8.23
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
ROE
-8.01
Higher than Peers by 32.38
Profit after tax / Average Net worth * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Charles River Laboratories (CRL)
|
-8.01
|
-4.36
|
0.29
|
14.44
|
17.65
|
|
Peer Median
|
-40.40
|
--
|
--
|
--
|
--
|
ROA
-2.76
Higher than Peers by 28.22
Profit after tax / Average Total assets * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Charles River Laboratories (CRL)
|
-2.76
|
-1.97
|
0.13
|
6.01
|
6.65
|
|
Peer Median
|
-30.98
|
--
|
--
|
--
|
--
|
EBIT Margin
-1.94
Higher than Peers by 81.68
Operating profit (EBIT) / Net Sales * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Charles River Laboratories (CRL)
|
-1.94
|
0.19
|
5.42
|
17.39
|
17.16
|
|
Peer Median
|
-83.62
|
--
|
--
|
--
|
--
|
Net Margin
-5.96
Higher than Peers by 86.71
Net profit / Total Income (Net sales plus other income) * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Charles River Laboratories (CRL)
|
-5.96
|
-3.59
|
0.25
|
11.49
|
12.13
|
|
Peer Median
|
-92.67
|
--
|
--
|
--
|
--
|
Cash Profit Margin
--
--
(Net profit + Depreciation) / Gross Sales * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Charles River Laboratories (CRL)
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
0.00
|
--
|
--
|
--
|
--
|
Revenue Growth
-0.74
Lower than Peers by 54.69
Year on year growth in net sales
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Charles River Laboratories (CRL)
|
-0.74
|
-0.01
|
-0.02
|
0.04
|
0.12
|
|
Peer Median
|
53.95
|
--
|
--
|
--
|
--
|
EBIT Growth
-178.82
Lower than Peers by 178.02
Year on year growth in operating profit (EBIT)
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Charles River Laboratories (CRL)
|
-178.82
|
-96.57
|
-69.44
|
5.23
|
23.02
|
|
Peer Median
|
-0.80
|
--
|
--
|
--
|
--
|
Net Profit Growth
-237.55
Lower than Peers by 230.25
Year on year growth in profit after tax
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Charles River Laboratories (CRL)
|
-237.55
|
-1,501.75
|
-97.83
|
-2.39
|
24.36
|
|
Peer Median
|
-7.30
|
--
|
--
|
--
|
--
|
EPS Growth
-266.27
Lower than Peers by 280.92
Year on year growth in earnings per share
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Charles River Laboratories (CRL)
|
-266.27
|
-15.56
|
-0.98
|
-0.03
|
0.25
|
|
Peer Median
|
14.65
|
--
|
--
|
--
|
--
|
Book Value Growth
-13.87
Lower than Peers by 3.69
Year on year growth in book value per share
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Charles River Laboratories (CRL)
|
-13.87
|
--
|
--
|
--
|
--
|
|
Peer Median
|
-10.18
|
--
|
--
|
--
|
--
|
Solvency
Debt to Equity
0.92
--
Total debt / Net worth
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Charles River Laboratories (CRL)
|
0.92
|
0.97
|
0.79
|
0.85
|
1.04
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Short term debt to equity ratio
--
--
(Short term borrowings / Net worth)
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Charles River Laboratories (CRL)
|
--
|
0.02
|
0.03
|
0.12
|
0.02
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Current Ratio
1.35
Lower than Peers by 4.46
Current Assets / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Charles River Laboratories (CRL)
|
1.35
|
1.29
|
1.41
|
1.52
|
1.32
|
|
Peer Median
|
5.81
|
--
|
--
|
--
|
--
|
Quick Ratio
1.04
Lower than Peers by 4.65
(Current Assets - Inventory) / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Charles River Laboratories (CRL)
|
1.04
|
1.02
|
1.13
|
1.16
|
1.08
|
|
Peer Median
|
5.70
|
--
|
--
|
--
|
--
|
Interest Coverage
-0.73
Higher than Peers by 1.36
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Charles River Laboratories (CRL)
|
-0.73
|
0.07
|
1.74
|
5.25
|
11.51
|
|
Peer Median
|
-2.09
|
--
|
--
|
--
|
--
|
Operating Efficiency
Debtors to sales
17.80
Lower than Peers by 1.34
Debtors outstanding / Net Sales * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Charles River Laboratories (CRL)
|
17.80
|
17.65
|
17.80
|
18.90
|
18.92
|
|
Peer Median
|
19.14
|
--
|
--
|
--
|
--
|
Asset Turnover
0.46
Higher than Peers by 0.40
Sales / Average Total Assets
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Charles River Laboratories (CRL)
|
0.46
|
0.55
|
0.52
|
0.52
|
0.54
|
|
Peer Median
|
0.06
|
--
|
--
|
--
|
--
|
Receivable days
--
--
Average Debtors / Sales * 365
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Charles River Laboratories (CRL)
|
--
|
65.03
|
67.70
|
67.79
|
64.43
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Inventory Days
--
--
Average Inventory / Sales * 365
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Charles River Laboratories (CRL)
|
--
|
37.81
|
44.26
|
44.22
|
33.06
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Payable days
--
--
Average Creditors / Cost of goods sold * 365
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Charles River Laboratories (CRL)
|
--
|
18.93
|
20.78
|
26.06
|
29.36
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Cash Conversion Cycle
--
--
Receivable Days + Inventory Days - Payable Days
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Charles River Laboratories (CRL)
|
--
|
83.91
|
91.18
|
85.95
|
68.13
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Valuation
Price / Earnings
--
--
Current share price divided by earning per share in the last twelve months
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Charles River Laboratories (CRL)
|
--
|
-68.02
|
916.78
|
25.71
|
23.02
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Price / Book Value
4.88
Lower than Peers by 0.31
Current share price divided by book value per share in the latest financial year
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Charles River Laboratories (CRL)
|
4.88
|
3.10
|
2.73
|
3.39
|
3.76
|
|
Peer Median
|
5.18
|
--
|
--
|
--
|
--
|
Dividend Yield
--
--
Dividend per share in the past twelve months divided by current share price
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Charles River Laboratories (CRL)
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EV/EBITDA
75.66
--
Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Charles River Laboratories (CRL)
|
75.66
|
30.84
|
20.60
|
14.53
|
14.25
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Market Cap
14,038
Higher than Peers by 13,892
Current Share price multiplied by latest total number of shares outstanding
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Charles River Laboratories (CRL)
|
14,038
|
--
|
--
|
--
|
--
|
|
Peer Median
|
146
|
--
|
--
|
--
|
--
|